Prosecution Insights
Last updated: October 01, 2026

Iridia Inc.

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

The portfolio for Iridia Inc. currently features 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is assigned to 1 distinct examiner, WOOLWINE, SAMUEL C, who serves as the busiest examiner with 1 pending case. All current prosecution activity is situated within 1 distinct art unit.

Because the company's active cases are limited to 1 distinct art unit, the technical focus of the portfolio is highly concentrated. The interaction with WOOLWINE, SAMUEL C is the sole determining factor for the resolution of the 1 pending office action. Practitioners should prioritize understanding the specific preferences of this examiner to ensure a favorable outcome.

With 1 distinct examiner overseeing the entire pending workload, there is no diversity in examination styles within the current Biotechnology & Pharmaceuticals portfolio. The centralized nature of this prosecution means that the company's immediate patent success depends on this single active matter. Future growth may eventually require navigating additional distinct art units or examiners.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
0
Non-Final OAs
0
Final Rejections
1
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
WOOLWINE, SAMUEL C 1 61.0% +20.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18152110 SYSTEMS AND METHODS FOR WRITING, READING, AND CONTROLLING DATA STORED IN A POLYMER WOOLWINE, SAMUEL C —

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18152110 SYSTEMS AND METHODS FOR WRITING, READING, AND CONTROLLING DATA STORED IN A POLYMER WOOLWINE, SAMUEL C —

Top Art Units

Art UnitApps
1681 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18152110 SYSTEMS AND METHODS FOR WRITING, READING, AND CONTROLLING DATA STORED IN A POLYMER WOOLWINE, SAMUEL C 1681 §102§112 Non-Final OA — Pending Jan 09, 2023

Managing Iridia Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month